Patent · US Active

Compound

US8450462B2 · kind B2 · utility

0Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 23, 2010
Grant dateMay 28, 2013
Priority date
Expiry dateJun 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound including a polymer is represented by general formula (1):L-Y-A  (1)wherein, A is a single-chain antibody moiety, which is a polypeptide including an antigen-binding site, L is a linker moiety, which is a polypeptide including a protease cleavage site, Y is a peptide moiety, which includes 0 or more amino acids connecting the linker moiety L with the single-chain antibody moiety A, and the linker moiety L binds to an N terminus of the peptide moiety Y or an N terminus of the single-chain antibody moiety A.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.